The Dr. Tyna Show

The Fight for Affordable GLP1s & the Truth About Big Pharma | Dave Knapp

Mar 27, 2025
Dave Knapp, an independent journalist and community leader, shares his compelling journey with obesity and type 2 diabetes while exploring GLP-1 receptor agonists. He discusses the FDA’s crackdown on compounding pharmacies and its implications for access to these vital medications. Knapp reveals how Pharmacy Benefit Managers manipulate drug prices, making health access more difficult. Additionally, he challenges traditional weight loss methods and highlights the urgency of addressing metabolic health issues in our communities.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Dave Knapp's Journey

  • Dave Knapp's background includes managing restaurants, leading to weight gain and type 2 diabetes.
  • His father's sudden death inspired him to start a marketing company.
ANECDOTE

Keto and Weight Loss

  • Despite a strict keto diet, Dave lost minimal weight while managing his A1C.
  • This led to a suggestion of bariatric surgery, which he resisted.
INSIGHT

GLP-1s and Metabolic Health

  • GLP-1 medications mimic hormonal changes after bariatric surgery.
  • They help level the metabolic playing field, improving overall health.
Get the Snipd Podcast app to discover more snips from this episode
Get the app